$1.17 +0.02 (1.74%)

TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD, Inc. (TXMD) is a women's health pharmaceutical company focused on developing and commercializing treatments in areas such as hormone therapy, contraceptives, and other women's health solutions. The company aims to address unmet needs within these markets through innovative products and therapies.

🚫 TherapeuticsMD, Inc. does not pay dividends

Company News

Sexual Wellness Market to Witness 4.7% CAGR by 2031 | SkyQuest Technology
Benzinga • Globe Newswire • October 3, 2024

The sexual wellness market is expected to grow at a CAGR of 4.7% by 2031, driven by increasing awareness of sexual health and the availability of a wide range of products. However, social stigma and regulatory challenges remain as key restraints.

All You Need to Know About TherapeuticsMD (TXMD) Rating Upgrade to Buy
Zacks Investment Research • Zacks Equity Research • April 14, 2023

TherapeuticsMD (TXMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

TherapeuticsMD, Inc. (TXMD) Q2 2022 Earnings Call Transcript
The Motley Fool • [email protected] (Motley Fool Transcribing) • August 15, 2022

TXMD earnings call for the period ending June 30, 2022.

Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market 
PennyStocks • J Dylan • May 20, 2022

Are these biotech penny stocks on your watchlist right now? The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.